Insider Trading History of Wong Keith

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Wong Keith since 2007. The trader's CIK number is 1384398. At the time of the last reporting, Wong Keith was the CEO of Cellular Biomedicine Group, Inc.. (stock ticker symbol CBMG). Also see all insider trading activities at Cellular Biomedicine Group, Inc..


Yearly summary of insider trading at Cellular Biomedicine Group, Inc. (CBMG) by Wong Keith

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 CBMG 0 $0 300,000 $1,500,000 0 $0
2012 CBMG 0 $0 320,050 $42,590 0 $0
2009 CBMG 7,300,000 $182,500 3,750,000 $150,000 0 $0
2008 CBMG 1,500,000 $60,000 1,800,000 $72,000 0 $0
2008 CBMG 6,333,333 $269,999 2,165,851 $117,768 0 $0
2007 CBMG 1,709,809 $503,638 328,840 $23,018 0 $0


Insider trading of Cellular Biomedicine Group, Inc. (CBMG) by Wong Keith

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-05-22 CBMG Sale 300,000 5.00 1,500,000
2012-07-23 CBMG Sale 12,600 .11 1,386
2013-07-09 CBMG Sale 400 6.60 2,640
2012-06-26 CBMG Sale 61,185 .09 5,200
2013-07-08 CBMG Sale 600 6.60 3,960
2012-02-23 CBMG Sale 50,000 .06 3,000
2012-06-18 CBMG Sale 3,815 .09 324
2013-03-04 CBMG Sale 1,000 7.18 7,180
2012-07-12 CBMG Sale 80,000 .11 8,800
2012-06-13 CBMG Sale 60,000 .07 4,200
2013-07-23 CBMG Sale 150 7.00 1,050
2012-02-03 CBMG Sale 50,000 .06 2,750
2013-07-19 CBMG Sale 300 7.00 2,100
2009-02-25 EBIG Buy 7,300,000 .03 182,500
2009-01-12 EBIG Sale 3,750,000 .04 150,000
2008-11-20 EBIG Buy 1,500,000 .04 60,000
2008-12-30 EBIG Sale 1,800,000 .04 72,000
2008-08-27 EBIG Buy 5,000,000 .03 150,000
2008-07-01 EBIG Sale 1,100,000 .04 38,500
2008-03-07 EBIG Sale 600,000 .07 42,000
2007-12-07 EBIG Sale 465,851 .08 37,268
2008-01-01 EBIG Buy 1,333,333 .09 119,999
2007-06-28 EBIG Sale 328,840 .07 23,018
2007-06-07 EBIG Buy 54,732 .13 7,115
2006-12-28 UNKNOWN Buy 1,655,077 .30 496,523

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wong Keith (CEO of Cellular Biomedicine Group, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.